Roche acquires Trophos to expand portfolio in neuromuscular disease with high medical need
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Novartis Pharmaceuticals announces a joint investment company with Qualcomm
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Acquisition provides Pfizer with a preclinical CMV vaccine candidate
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Novartis collaborates with Intellia Therapeutics and Caribou Biosciences
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
More Pharma News ...
- New European consortium formed to help further advance development of a GSK/NIH Ebola candidate vaccine
- Abbott completes acquisition of Veropharm
- Pfizer expands rare disease research with establishment of gene therapy platform
- Jury verdict favours AstraZeneca in Nexium antitrust litigation
- Bristol-Myers Squibb Foundation awards nine grants to support care for high-risk patients with hepatitis B and C in China and India
- Amgen and AstraZeneca announce positive results from third and final pivotal Phase III study of Brodalumab in patients with moderate-to-severe plaque psoriasis
- GSK statement on first phase 1 trial results of a candidate Ebola vaccine